(Q34086039)

30 July 2017

title

SB-243213; a selective 5-HT2C receptor inverse agonist with improved anxiolytic profile: lack of tolerance and withdrawal anxiety (English)

1 reference

30 July 2017

Wood MD

1

1 reference

30 July 2017

Reavill C

2

1 reference

30 July 2017

Trail B

3

1 reference

30 July 2017

Wilson A

4

1 reference

30 July 2017

Stean T

5

1 reference

30 July 2017

Kennett GA

6

1 reference

30 July 2017

Lightowler S

7

1 reference

30 July 2017

Blackburn TP

8

1 reference

30 July 2017

Thomas D

9

1 reference

30 July 2017

Gager TL

10

1 reference

30 July 2017

Riley G

11

1 reference

30 July 2017

Holland V

12

1 reference

30 July 2017

Bromidge SM

13

1 reference

30 July 2017

Forbes IT

14

1 reference

30 July 2017

Middlemiss DN

15

1 reference

30 July 2017

publication date

1 August 2001

1 reference

30 July 2017

1 reference

30 July 2017

volume

41

1 reference

30 July 2017

issue

2

1 reference

30 July 2017

page(s)

186-199

1 reference

Localization of the 5-hydroxytryptamine2C receptor protein in human and rat brain using specific antisera.

30 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2801%2900054-5

Evidence that the median raphé nucleus--dorsal hippocampal pathway mediates diazepam withdrawal-induced anxiety

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2801%2900054-5

An autoradiographic analysis of the differential ascending projections of the dorsal and median raphe nuclei in the rat

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2801%2900054-5

Effect of drugs influencing central serotonergic mechanisms on haloperidol-induced catalepsy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2801%2900054-5

Biarylcarbamoylindolines are novel and selective 5-HT(2C) receptor inverse agonists: identification of 5-methyl-1-[[2-[(2-methyl-3-pyridyl)oxy]- 5-pyridyl]carbamoyl]-6-trifluoromethylindoline (SB-243213) as a potential antidepressant/anxiolytic agent

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2801%2900054-5

Competitive antagonism of serotonin (5-HT)2C and 5-HT2A receptor-mediated phosphoinositide (PI) turnover by clozapine in the rat: a comparison to other antipsychotics

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2801%2900054-5

Repeated treatment with imipramine and amitriptyline reduced the immobility of rats in the swimming test by enhancing dopamine mechanisms in the nucleus accumbens

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2801%2900054-5

Pharmacological characterization of extracellular acidification rate responses in human D2(long), D3 and D4.4 receptors expressed in Chinese hamster ovary cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2801%2900054-5

SB 242084, a selective serotonin2C receptor antagonist, increases dopaminergic transmission in the mesolimbic system

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2801%2900054-5

A role for the subthalamic nucleus in 5-HT2C-induced oral dyskinesia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2801%2900054-5

The effect of treatment regimen on the development of tolerance to the sedative and anxiolytic effects of diazepam

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2801%2900054-5

The use of social interaction as a method for detecting anxiolytic activity of chlordiazepoxide-like drugs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2801%2900054-5

Behavioral effects of 5-HT2C receptor antagonism in the substantia nigra zona reticulata of the 6-hydroxydopamine-lesioned rat model of Parkinson's disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2801%2900054-5

Evidence for 5-HT2 involvement in the mechanism of action of hallucinogenic agents

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2801%2900054-5

m-Chlorophenylpiperazine as a probe of serotonin function

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2801%2900054-5

Cataleptogenic effect of subtype selective 5-HT receptor antagonists in the rat

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2801%2900054-5

In vitro and in vivo profile of SB 206553, a potent 5-HT2C/5-HT2B receptor antagonist with anxiolytic-like properties

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2801%2900054-5

SB 242084, a selective and brain penetrant 5-HT2C receptor antagonist

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2801%2900054-5

In vivo properties of SB 200646A, a 5-HT2C/2B receptor antagonist

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2801%2900054-5

5HT2C receptor agonists exhibit antidepressant-like properties in the anhedonia model of depression in rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2801%2900054-5

5-HT2 receptor antagonism reduces hyperactivity induced by amphetamine, cocaine, and MK-801 but not D1 agonist C-APB

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2801%2900054-5

Distribution and cellular localization of the serotonin type 2C receptor messenger RNA in human brain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2801%2900054-5

Treatment of neuroleptic-induced akathisia with the 5-HT2 antagonist mianserin. Double-blind, placebo-controlled study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2801%2900054-5

Serotonergic agents in the treatment of acute neuroleptic-induced akathisia: open-label study of buspirone and mianserin.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2801%2900054-5

5-HT4 receptor antagonism does not affect motor and reward mechanisms in the rat.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2801%2900054-5

Attenuation of haloperidol-induced catalepsy by a 5-HT2C receptor antagonist

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2801%2900054-5

Eating disorder and epilepsy in mice lacking 5-HT2c serotonin receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2801%2900054-5

m-Chlorophenylpiperazine (mCPP) is an antagonist at the cloned human 5-HT2B receptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2801%2900054-5

Comparative localization of serotonin1A, 1C, and2 receptor subtype mRNAs in rat brain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2801%2900054-5

10.1016/S0028-3908(01)00054-5

7 January 2021

Identifiers

DOI

1 reference

30 July 2017

1 reference